4//SEC Filing
Taiho Ventures LLC 4
Accession 0000899243-21-018120
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:31 PM ET
Size
12.7 KB
Accession
0000899243-21-018120
Insider Transaction Report
Form 4
Taiho Ventures LLC
10% Owner
Transactions
- Purchase
Common Stock
2021-05-04$16.00/sh+312,500$5,000,000→ 2,068,909 total - Conversion
Series B Preferred Stock
2021-05-04−3,797,921→ 0 total→ Common Stock (438,098 underlying) - Conversion
Common Stock
2021-05-04+1,318,311→ 1,318,311 total - Conversion
Common Stock
2021-05-04+438,098→ 1,756,409 total - Conversion
Series A Preferred Stock
2021-05-04−11,428,570→ 0 total→ Common Stock (1,318,311 underlying)
Footnotes (2)
- [F1]On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001857906
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:31 PM ET
- Size
- 12.7 KB